Cargando…
Correction: Evidence for Reduced Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monotherapy Failure in the SARA Trial
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4890937/ https://www.ncbi.nlm.nih.gov/pubmed/27254277 http://dx.doi.org/10.1371/journal.pone.0157094 |
| _version_ | 1782435188295335936 |
|---|---|
| author | Sutherland, Katherine A. Parry, Chris M. McCormick, Adele Kapaata, Anne Lyagoba, Fred Kaleebu, Pontiano Gilks, Charles F. Goodall, Ruth Spyer, Moira Kityo, Cissy Pillay, Deenan Gupta, Ravindra K. |
| author_facet | Sutherland, Katherine A. Parry, Chris M. McCormick, Adele Kapaata, Anne Lyagoba, Fred Kaleebu, Pontiano Gilks, Charles F. Goodall, Ruth Spyer, Moira Kityo, Cissy Pillay, Deenan Gupta, Ravindra K. |
| author_sort | Sutherland, Katherine A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4890937 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2016 |
| publisher | Public Library of Science |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-48909372016-06-10 Correction: Evidence for Reduced Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monotherapy Failure in the SARA Trial Sutherland, Katherine A. Parry, Chris M. McCormick, Adele Kapaata, Anne Lyagoba, Fred Kaleebu, Pontiano Gilks, Charles F. Goodall, Ruth Spyer, Moira Kityo, Cissy Pillay, Deenan Gupta, Ravindra K. PLoS One Correction Public Library of Science 2016-06-02 /pmc/articles/PMC4890937/ /pubmed/27254277 http://dx.doi.org/10.1371/journal.pone.0157094 Text en © 2016 Sutherland et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| spellingShingle | Correction Sutherland, Katherine A. Parry, Chris M. McCormick, Adele Kapaata, Anne Lyagoba, Fred Kaleebu, Pontiano Gilks, Charles F. Goodall, Ruth Spyer, Moira Kityo, Cissy Pillay, Deenan Gupta, Ravindra K. Correction: Evidence for Reduced Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monotherapy Failure in the SARA Trial |
| title | Correction: Evidence for Reduced Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monotherapy Failure in the SARA Trial |
| title_full | Correction: Evidence for Reduced Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monotherapy Failure in the SARA Trial |
| title_fullStr | Correction: Evidence for Reduced Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monotherapy Failure in the SARA Trial |
| title_full_unstemmed | Correction: Evidence for Reduced Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monotherapy Failure in the SARA Trial |
| title_short | Correction: Evidence for Reduced Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monotherapy Failure in the SARA Trial |
| title_sort | correction: evidence for reduced drug susceptibility without emergence of major protease mutations following protease inhibitor monotherapy failure in the sara trial |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4890937/ https://www.ncbi.nlm.nih.gov/pubmed/27254277 http://dx.doi.org/10.1371/journal.pone.0157094 |
| work_keys_str_mv | AT sutherlandkatherinea correctionevidenceforreduceddrugsusceptibilitywithoutemergenceofmajorproteasemutationsfollowingproteaseinhibitormonotherapyfailureinthesaratrial AT parrychrism correctionevidenceforreduceddrugsusceptibilitywithoutemergenceofmajorproteasemutationsfollowingproteaseinhibitormonotherapyfailureinthesaratrial AT mccormickadele correctionevidenceforreduceddrugsusceptibilitywithoutemergenceofmajorproteasemutationsfollowingproteaseinhibitormonotherapyfailureinthesaratrial AT kapaataanne correctionevidenceforreduceddrugsusceptibilitywithoutemergenceofmajorproteasemutationsfollowingproteaseinhibitormonotherapyfailureinthesaratrial AT lyagobafred correctionevidenceforreduceddrugsusceptibilitywithoutemergenceofmajorproteasemutationsfollowingproteaseinhibitormonotherapyfailureinthesaratrial AT kaleebupontiano correctionevidenceforreduceddrugsusceptibilitywithoutemergenceofmajorproteasemutationsfollowingproteaseinhibitormonotherapyfailureinthesaratrial AT gilkscharlesf correctionevidenceforreduceddrugsusceptibilitywithoutemergenceofmajorproteasemutationsfollowingproteaseinhibitormonotherapyfailureinthesaratrial AT goodallruth correctionevidenceforreduceddrugsusceptibilitywithoutemergenceofmajorproteasemutationsfollowingproteaseinhibitormonotherapyfailureinthesaratrial AT spyermoira correctionevidenceforreduceddrugsusceptibilitywithoutemergenceofmajorproteasemutationsfollowingproteaseinhibitormonotherapyfailureinthesaratrial AT kityocissy correctionevidenceforreduceddrugsusceptibilitywithoutemergenceofmajorproteasemutationsfollowingproteaseinhibitormonotherapyfailureinthesaratrial AT pillaydeenan correctionevidenceforreduceddrugsusceptibilitywithoutemergenceofmajorproteasemutationsfollowingproteaseinhibitormonotherapyfailureinthesaratrial AT guptaravindrak correctionevidenceforreduceddrugsusceptibilitywithoutemergenceofmajorproteasemutationsfollowingproteaseinhibitormonotherapyfailureinthesaratrial AT correctionevidenceforreduceddrugsusceptibilitywithoutemergenceofmajorproteasemutationsfollowingproteaseinhibitormonotherapyfailureinthesaratrial |